Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center

• Status: Completed
• Trial end date: 2021-02-04
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if a single dose of sublingual sufentanil given 15-30 minutes prior to wake up is efficacious at reducing recovery room time.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Minnesota
• Treatments: Sufentanil

Criteria

Inclusion Criteria:

• Adult patients undergoing outpatient ambulatory surgery undergoing general anesthesia for orthopedic surgery

Exclusion Criteria:

• non-english speaking patients

• patients who have allergy or intolerance to the study drugs or derivatives